Search

Your search keyword '"Ellinger, J."' showing total 586 results

Search Constraints

Start Over You searched for: Author "Ellinger, J." Remove constraint Author: "Ellinger, J."
586 results on '"Ellinger, J."'

Search Results

103. Die Mediatorkomplex Untereinheit MED15: Ein Tumorpromotor im Nierenzellkarzinom

104. Analyse der Genregulation von Mitgliedern der mitochondrialen Elektronentransportkette bei Patienten mit einem Nierenzellkarzinom

105. Identification of aberrant expression of tRNA halves in renal cell carcinoma

106. The Mediator complex subunit MED8 is implicated in the progression of renal cell carcinoma

107. Identification of novel biomarkers in clear cell renal cell carcinoma

110. Prädiktion des krebsspezifischen Überlebens nach radikaler Zystektomie beim Harnblasenkarzinom unter Anwendung artifizieller neuronaler Netzwerke

111. Transplantat-Nephrektomie - Bonner Erfahrungen von 1999-2012

112. Die Bedeutung der Mediator-Komplex Untereinheit MED12 während der Progression des muskelinvasiven Blasenkarzinoms

113. Erstvorstellung der onkologischen TRIFECTA- und PENTAFECTA-Kriterien zur Verbesserung der Prognosestratifizierung nach radikaler Zystektomie

114. Identification of novel biomarkers for patients with renal cell carcinoma

115. The Mediator complex subunit MED8 is implicated in the progression of renal cell carcinoma

121. Prädiktion des krebsspezifischen Überlebens nach radikaler Zystektomie beim Harnblasenkarzinom unter Anwendung artifizieller neuronaler Netzwerke

123. Erstvorstellung der onkologischen TRIFECTA- und PENTAFECTA-Kriterien zur Verbesserung der Prognosestratifizierung nach radikaler Zystektomie

128. 538 Prediction of cancer-specific survival in patients with radical cystectomy for bladder cancer using artificial neural networks

129. 756 The Mediator complex subunit MED12 is implicated in the progression of urothelial cell carcinoma of the urinary bladder

130. H3+ as a trap for noble gases-3: Multiple trapping of neon, argon, and krypton in XnH3+ (n=1–3)

133. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation

134. 286 Clinical and pathological nodal staging score for urothelial carcinoma of the bladder are valid decision tools for risk assessment and clinical decision-making: An external validation

135. 775 Female gender is associated with worse cancer-specific survival after radical cystectomy for urothelial bladder carcinoma: Multicenter analysis of 2,483 patients

136. 872 External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial carcinoma of the bladder

137. 244 MULTICENTRIC VALIDATION OF NOMOGRAMS TO PREDICT LOCALLY ADVANCED UROTHELIAL CANCER OF THE BLADDER AND SURVIVAL RATES FOLLOWING RADICAL CYSTECTOMY

138. 866 ASSOCIATION BETWEEN THE EXTENT OF PELVIC LYMPHADENECTOMY AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER UNDERGOING RADICAL CYSTECTOMY

139. 243 PREDICTION OF LOCALLY ADVANCED BLADDER CANCER BEFORE CYSTECTOMY AND OUTCOME ASSESSMENT OF PATIENTS WITH BLADDER CANCER AFTER CYSTECTOMY USING ARTIFICIAL NEURAL NETWORKS

140. Autorenverzeichnis

144. Prostatakarzinomforschung

150. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.

Catalog

Books, media, physical & digital resources